Furthermore, in the ILC1s transfer assay, we do not find direct evidence that proved that the increased percentage of ILC1s in the tumor microenvironment is attributed to adoptive transfer, so the use of CD45 congenic mice and/or labeling the adoptively transferred ILC1s is needed to further prove our results in future work. Here, PTPRC is linked to neoplasm.